A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment (STRIKE)
STRIKE - Treating Patients With Early Axial Spondyloarthritis to Target - a 1 Year Randomized Controlled Study Taking an Intense Treatment Approach Versus Routine Treatment
Sponsor: AbbVie
Terminated
The study was terminated due to slow recruitment.
Other terminated trials from AbbVie
Other Axial Spondyloarthritis trials with similar outcome
This PHASE4 trial investigates Axial Spondyloarthritis and is currently terminated or withdrawn. AbbVie leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Mar 2022 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2022 — Mar 2022 [monthly]
Terminated PHASE4
-
Jan 2021 — Jan 2022 [monthly]
Terminated PHASE4
▶ Show 8 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Terminated PHASE4
Status: Completed → Terminated
-
Jun 2018 — Aug 2019 [monthly]
Completed PHASE4
-
Jan 2018 — Jun 2018 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Dec 2017 — Jan 2018 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Aug 2017 — Dec 2017 [monthly]
Recruiting PHASE4
-
May 2017 — Aug 2017 [monthly]
Recruiting PHASE4
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AbbVie
- Hannover Medical School
- IST GmbH, Germany
- Improvement by Movement GmbH, Germany
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.